From: Therapeutic applications of nucleic acid aptamers in microbial infections
Target type | Aptamer Name | Target | Aptamer Type | Sequence of the Aptamer (5′ to 3′) | Kd (nM) | Ref |
---|---|---|---|---|---|---|
Bacteria | Lyd-3 | S. pneumoniae | DNA | TGACGAGCCCAAGTTACCTGCCCCCGAACCATACCACACG ATGCCCCGTACCCCAGCCACCAGAATCTCCGCTGCCTACA | 661.8 ± 111.3 | [29] |
Apt3 | S. choleraesuis | DNA | GGCAGGACAACAGCGTGTAGTATCAGCTTACGGTG | 41 ± 2 | [11] | |
BB16-11f | B. brevea | DNA | CTCCCAGGCCGTTGGGGCGTTGCCTGCGT | 18.66 ± 1.41 | [30] | |
CCFM641–5 | B. bifidumb | DNA | TGCGTGAGCGGTAGCCCCGTACGACCCACTGTGGTTGGGC | 10.69 ± 0.89 | [18] | |
SAL 26 | S.typhimurium | DNA | TAGCTCACTCATTAGGCACATTTGTGGCACCAAATTTGAATTAATCAAGACAGTGTGGTGCATAGTTAAGCCAGCC | 123 ± 23 | [31] | |
Bacterial toxin | CT916 | cholera toxin | DNA | GGCAAAAAGGATTGCCCAGGTCTGCTGTCTAGCCGGATTC | 48.5 ± 0.5 | [32] |
S3 | SEA | DNA | CCCGCCTCTGAGCATTATTAATGTTATACCTTACGGCTGG | 36.93 ± 7.29 | [33] | |
ML12 | LF | DNA | CGAGGGAGACGCGAACCTTCTCGCCTTGGG | 11.0 ± 2.7 | [34] | |
C10 | enterotoxin C1 | DNA | AGCAGCACAGAGGTCAGATGTATACTTCTAAAATTTGTTTGT ATCTACGATGTTCTTCGTCCTATGCGTGCTACCGTGAA | 65.14 ± 11.64 | [35] |